|
1
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y and Wu S: Novel therapy for
advanced gastric cancer. World J Gastrointest Oncol. 7:263–270.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan S, He F, Luo R, Wu H, Huang M, Huang
C, Li Y and Zhou Z: Decreased expression of BRCA1-associated
protein 1 predicts unfavorable survival in gastric adenocarcinoma.
Tumor Biol. 37:6125–6133. 2016. View Article : Google Scholar
|
|
5
|
Wen R, Gao F, Zhou CJ and Jia YB:
Polymorphisms in mucin genes in the development of gastric cancer.
Word J Gastrointest Oncol. 7:328–337. 2015. View Article : Google Scholar
|
|
6
|
Wang L, Zhu JS, Song MQ, Chen GQ and Chen
JL: Comparison of gene expression profiles between primary tumor
and metastatic lesions in gastric cancer patients using laser
microdissection and cDNA microarray. Word J Gastroenterol.
12:6949–6954. 2006. View Article : Google Scholar
|
|
7
|
Gu P, Xing X, Tänzer M, Röcken C, Weichert
W, Ivanauskas A, Pross M, Peitz U, Malfertheiner P, Schmid RM and
Ebert MP: Frequent loss of TIMP-3 expression in progression of
esophageal and gastric adenocarcinomas. Neoplasia. 10:563–572.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi K, Inokuchi M, Takagi Y, Otsuki
S, Fujimori Y, Sato Y, Yanaka Y, Higuchi K, Aburatani T, Tomii C,
et al: Prognostic significance of PAK4 expression in gastric
cancer. J Clin Pathol. 69:580–585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li C, Tang L, Zhao L, Li L, Xiao Q, Luo X,
Peng W, Ren G, Tao Q and Xiang T: OPCML is frequently methylated in
human colorectal cancer and its restored expression reverses EMT
via downregulation of smad signaling. Am J Cancer Res. 5:1635–1648.
2015.PubMed/NCBI
|
|
10
|
Sanz R, Ferraro GB and Fournier AE: IgLON
cell adhesion molecules are shed from the cell surface of cortical
neurons to promote neuronal growth. J Biol Chem. 290:4330–4342.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Minhas HM, Pescosolido MF, Schwede M,
Piasecka J, Gaitanis J, Tantravahi U and Morrow EM: An unbalanced
translocation involving loss of 10q26.2 and gain of 11q25 in a
pedigree with autism spectrum disorder and cerebellar juvenile
pilocytic astrocytoma. Am J Med Genet A. 161A:787–791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou F, Tao G, Chen X, Xie W, Liu M and
Cao X: Methylation of OPCML promoter in ovarian cancer tissues
predicts poor patient survival. Clin Chem Lab Med. 52:735–742.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou F, Ma M, Tao G, Chen X, Xie W, Wang Y
and Cao X: Detection of circulating methylated opioid binding
protein/cell adhesion molecule-like gene as a biomarker for ovarian
carcinoma. Clin Lab. 60:759–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu SY and Sood AK: New roles opined for
OPCML. Cancer Discov. 2:115–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McKie AB, Vaughan S, Zanini E, Okon IS,
Louis L, de Sousa C, Greene MI, Wang Q, Agarwal R, Shaposhnikov D,
et al: The OPCML tumor suppressor functions as a cell surface
repressor-adaptor, negatively regulating receptor tyrosine kinases
in epithelial ovarian cancer. Cancer Discov. 2:156–171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amoenpisutt R, Proungvitaya S,
Jearanaikoon P and Limpaiboon T: DNA methylation level of OPCML and
SFRP1: A potential diagnostic biomarker of cholangiocarcinoma.
Tumor Biol. 36:4973–4978. 2015. View Article : Google Scholar
|
|
17
|
Rein BJ, Gupta S, Dada R, Safi J, Michener
C and Agarwal A: Potential markers for detection and monitoring of
ovarian cancer. J Oncol. 2011:4759832011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Xiang J, Chen DF, Ni BB, Chen H,
Fan XJ, Wang PN, Song SX, Fang LK, Xiao HY, et al: Screening for
differentially methylated genes among human colorectal cancer
tissues and normal mucosa by microarray chip. Mol Biol Rep.
40:3457–3464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reed JE, Dunn JR, du Plessis DG, Shaw EJ,
Reeves P, Gee AL, Warnke PC, Sellar GC, Moss DJ and Walker C:
Expression of cellular adhesion molecule ‘OPCML’ is down-regulated
in gliomas and other brain tumours. Neuropathol Appl Neurobiol.
33:77–85. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amornpisutt R, Sriraksa R and Limpaiboon
T: Validation of methylation-sensitive high resolution melting for
the detection of DNA methylation in cholangiocarcinoma. Clin
Biochem. 45:1092–1094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J,
Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, et al: OPCML is a broad
tumor suppressor for multiple carcinomas and lymphomas with
frequently epigenetic inactivation. PLoS One. 3:e29902008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang B, Yu L, Yang GZ, Luo X and Huang L:
Applicaion of multiplex nested methylated specific PCR in early
diagnosis of epithelial ovarian cancer. Asian Pac J Cancer Prev.
16:3003–3007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye F, Zhang SF, Xie X and Lu WG: OPCML
gene promoter methylation and gene expression in tumor and stroma
cells of invasive cervical carcinoma. Cancer Invest. 26:569–574.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Hu G, Yang Q, Dong R, Xie X, Ma
D, Shen K and Kong B: A multiplex methylation-specific PCR assay
for the detection of early-stage ovarian cancer using cell-free
serum DNA. Gynecol Oncol. 130:132–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
